Optimization and characterization of bacterial nanocellulose produced by Komagataeibacter rhaeticus K3

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.carpta.2020.100022.In this work, a novel Bacterial NanoCellulose (BNC) producing strain, from Kombucha tea, was isolated and characterized. Based on 16S rRNA analysis the strain was identified as Komagataeibacter rhaeticus. Under static culture, K. rhaeticus K3 produces membranes with a relaxed structure, as observed by Scanning Electron Microscopy (SEM). The addition of 2% (v/v) ethanol to the culture media enhanced by more than 3-fold of the BNC yield. Response surface methodology (RSM) was performed with K. rhaeticus K3, using a new low cost Eucalyptus Biomass Hydrolysate (EBH). The maximum experimental BNC yield was of 5.46 g/L, obtained with the following composition: 31.4 g/L of EBH; 2.89% (v/v) of ethanol and 10.8 g/L of Yeast extract/peptone. Texture Profile Analysis (TPA) of BNC membranes obtained using Hestrin-Schramm culture (HS) medium and optimized medium from EBH showed that membranes from EBH had higher resistance to compression, higher cohesiveness and resilience.This study was supported with the funds of Institute of Technical Biochemistry, Lodz University of Technology, Lodz, Poland and from The Navigator Company through the I&D no. 21874, “Inpactus-– Produtos e Tecnologias Inovadores a partir do Eucalipto”, funded through the Fundo Europeu de Desenvolvimento Regional (FEDER) and the Programa Operacional Competitividade e Internacionalização (POCI) is greatly acknowledged. This study was also supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI01-0145-FEDER-006684) and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by the European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte.” The authors also acknowledge the financial support of the FCT (ESF) through the grant given to Francisco A.G. Soares da Silva (SFRH/BD/146375/2019).info:eu-repo/semantics/publishedVersio

Knowledge synthesis of benefits and adverse effects of measles vaccination: the Lasbela balance sheet

<p>Abstract</p> <p>Background</p> <p>In preparation for a cluster-randomized controlled trial of a community intervention to increase the demand for measles vaccination in Lasbela district of Pakistan, a balance sheet summarized published evidence on benefits and possible adverse effects of measles vaccination.</p> <p>Methods</p> <p>The balance sheet listed: 1) major health conditions associated with measles; 2) the risk among the unvaccinated who contract measles; 3) the risk among the vaccinated; 4) the risk difference between vaccinated and unvaccinated; and 5) the likely net gain from vaccination for each condition.</p> <p>Results</p> <p>Two models revealed very different projections of net gain from measles vaccine. A Lasbela-specific combination of low period prevalence of measles among the unvaccinated, medium vaccination coverage and low vaccine efficacy rate, as revealed by the baseline survey, resulted in less-than-expected gains attributable to vaccination. Modelled on estimates where the vaccine had greater efficacy, the gains from vaccination would be more substantial.</p> <p>Conclusion</p> <p>Specific local conditions probably explain the low rates among the unvaccinated while the high vaccine failure rate is likely due to weaknesses in the vaccination delivery system. Community perception of these realities may have had some role in household decisions about whether to vaccinate, although the major discouraging factor was inadequate access. The balance sheet may be useful as a communication tool in other circumstances, applied to up-to-date local evidence.</p

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points